Related references
Note: Only part of the references are listed.2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Marc Humbert et al.
EUROPEAN RESPIRATORY JOURNAL (2023)
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease
Orly Leiva et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2023)
Pulmonary thromboendarterectomy: The Marie Lannelongue Hospital experience
Olaf Mercier et al.
ANNALS OF CARDIOTHORACIC SURGERY (2022)
BCR-ABL1-Negative Chronic Myeloproliferative Neoplasms and Pulmonary Hypertension: A Prospective Long-Term Follow-up Study of the Impact of Pulmonary Hypertension on Survival
Kadriye Bahriye Payzin et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2021)
Prevalence and risk factors for Pulmonary Hypertension associated with chronic Myeloproliferative Neoplasms
Alberto Ferrari et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2021)
Pulmonary hypertension is associated with increased nonrelapse mortality after allogeneic hematopoietic cell transplantation for myelofibrosis
Rohan Gupta et al.
BONE MARROW TRANSPLANTATION (2020)
Chronic inflammation within the vascular wall in pulmonary arterial hypertension: more than a spectator
Alice Huertas et al.
CARDIOVASCULAR RESEARCH (2020)
Prevalence of pulmonary hypertension in myelofibrosis
Juan Lopez-Mattei et al.
ANNALS OF HEMATOLOGY (2020)
Long-term Effects of the Janus Kinase 1/2 Inhibitor Ruxolitinib on Pulmonary Hypertension and the Cardiac Function in a Patient with Myelofibrosis
Hiroshi Miyawaki et al.
INTERNAL MEDICINE (2020)
Pulmonary complications of Bcr-Abl tyrosine kinase inhibitors
Jason Weatherald et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Prevalence and risk factors of high echocardiographic probability of pulmonary hypertension in myeloproliferative neoplasms patients
Yanika Jindamai et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)
Pulmonary hypertension in patients with Philadelphia-negative myeloproliferative neoplasms: a single-center retrospective analysis of 225 patients
Myung-Won Lee et al.
BLOOD RESEARCH (2020)
Vascular endothelial cell expression of JAK2(V617F) is sufficient to promote a pro-thrombotic state due to increased P-selectin expression
Alexandre Guy et al.
HAEMATOLOGICA (2019)
Pulmonary arterial hypertension associated with protein kinase inhibitors: a pharmacovigilance-pharmacodynamic study
Lucie Cornet et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Prevalence and Effect on Survival of Pulmonary Hypertension in Myelofibrosis
Matthew Austin et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)
Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients
Geoffroy Venton et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2019)
Pathogenesis and Management of Thrombotic Disease in Myeloproliferative Neoplasms
Deepa R. J. Arachchillage et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2019)
A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline
Mary Frances McMullin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Frequency and etiology of pulmonary hypertension in patients with myeloproliferative neoplasms
Mette Brabrand et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2019)
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
Gerald Simonneau et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Incremental Utility of Right Ventricular Dysfunction in Patients With Myeloproliferative Neoplasm-Associated Pulmonary Hypertension
Jiwon Kim et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2019)
Pharmacovigilance in a rare disease: example of the VIGIAPATH program in pulmonary arterial hypertension
Marie-Camille Chaumais et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY (2018)
Long-term outcomes of dasatinib-induced pulmonary arterial hypertension: a population-based study
Jason Weatherald et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
Athenais Boucly et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Pulmonary Hypertension Associated with Pulmonary Veno-occlusive Disease in Patients with Polycythemia Vera
Takayoshi Tachibana et al.
INTERNAL MEDICINE (2017)
Pulmonary extra-medullary hematopoiesis and pulmonary hypertension from underlying polycythemia vera: a case series
Inderjit Singh et al.
PULMONARY CIRCULATION (2017)
Correlation between JAK2 allele burden and pulmonary arterial hypertension and hematological parameters in Philadelphia negative JAK2 positive myeloproliferative neoplasms. An Egyptian experience
Mervat M. Mattar et al.
ANNALS OF HEMATOLOGY (2016)
Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity
Marianne Riou et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Resolution of myelofibrosis-associated pulmonary arterial hypertension following allogeneic hematopoietic stem cell transplantation
Saadia A. Faiz et al.
Pulmonary Circulation (2016)
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
Nazzareno Galie et al.
EUROPEAN RESPIRATORY JOURNAL (2015)
Pulmonary hypertension in patients with chronic myeloproliferative disorders
Yochai Adir et al.
EUROPEAN RESPIRATORY REVIEW (2015)
Pulmonary extramedullary hematopoiesis involving the pulmonary artery
Varun Monga et al.
HEMATOLOGY REPORTS (2015)
Inflammation and Immunity in the Pathogenesis of Pulmonary Arterial Hypertension
Marlene Rabinovitch et al.
CIRCULATION RESEARCH (2014)
ExtramedulLary Pulmonary Hematopoiesis Causing Pulmonary Hypertension and Severe Tricuspid Regurgitation Detected by Technetium-99m Sulfur Colloid Bone Marrow Scan and Single-Photon Emission Computed Tomography/CT
Syed Zama Ali et al.
KOREAN JOURNAL OF RADIOLOGY (2014)
Ruxolitinib leads to improvement of pulmonary hypertension in patients with myelofibrosis
A. Tabarroki et al.
LEUKEMIA (2014)
Unexplained dyspnoea in a patient with idiopathic myelofibrosis
Praveen Pissay Gopala Rao et al.
THORAX (2013)
Pulmonary Arterial Hypertension in Patients Treated by Dasatinib
David Montani et al.
CIRCULATION (2012)
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Results From an International Prospective Registry
Joanna Pepke-Zaba et al.
CIRCULATION (2011)
Genetic and Epigenetic Complexity in Myeloproliferative Neoplasms
Nicholas C. P. Cross
HEMATOLOGY-AMERICAN SOCIETY HEMATOLOGY EDUCATION PROGRAM (2011)
Pulmonary veno-occlusive disease in myeloproliferative disorder
E. Willems et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Thrombosis in myeloproliferative disorders: pathogenetic facts and speculation
R. Landolfi et al.
LEUKEMIA (2008)
Pulmonary hypertension associated with myeloproliferative disorders: A retrospective study of ten cases
P. Guilpain et al.
RESPIRATION (2008)
Leukocytosis is a risk factor for thrombosis in essential thrombocythemia: interaction with treatment, standard risk factors, and Jak2 mutation status
Alessandra Carobbio et al.
BLOOD (2007)
Pulmonary hypertension in patients with essential thrombocythemia and reactive thrombocytosis
Abdullah Altintas et al.
LEUKEMIA & LYMPHOMA (2007)
Pulmonary arterial hypertension in France - Results from a national registry
M Humbert et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
A gain-of-function mutation of JAK2 in myeloproliferative disorders
R Kralovics et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Functional and morphological cardiac changes in myeloproliferative disorders (clinical study)
G Kadikoylu et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2004)
Nonhepatosplenic extramedullary hematopoiesis: Associated diseases, pathology, clinical course, and treatment
CA Koch et al.
MAYO CLINIC PROCEEDINGS (2003)
A 25-year clinical history of portopulmonary hypertension associated with latent myeloproliferative disorder
H Ito et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Unexplained pulmonary hypertension in chronic myeloproliferative disorders
D Dingli et al.
CHEST (2001)
Share Paper
